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ABSTRACT 
Obesity is now present worldwide, including China, India and developing countries. It now seems no longer acceptable 
to argue that obesity can simply be explained in terms of caloric consumption only using simple concept of energy in 
and energy out. There may be specific causes of altered metabolism that produce nutritional imbalances. Individual 
variation in response to food intake may also be considered. Specific substances in the food chain can influence me-
tabolism towards an increase in fat deposits. Xenoestrogens have been suggested to have such an influence. Soy con-
tains phytoestrogens plus phytates, protease inhibitors and other anti-nutrients which block or compromise the body’s 
uptake of essential vitamins and minerals. This may contribute to nutritional anomalies. We analyzed data from WHO 
and FAO for 167 countries. These contained percentage of obese individuals (BMI > 30 kg/m2), GDP, caloric consump-
tion per capita, and sugar and soy consumption per capita. Regressions and partial correlations were used. Soy con-
sumption correlates significantly with levels of obesity, irrespective of GDP and caloric intake. For instance, poor Latin 
America with soy consumption of 28.9 kg/person/year has more obesity (18.4%) than better off European Union 
(14.1%) consuming 16.1 kg/person/year of soy. Soy consumption seems to contribute approximately 10% - 21% to the 
worldwide variation in obesity, depending on the method of statistical analysis. The ubiquitous presence of unfermented 
soy products in mass produced foods seems to be an important contributor to the obesity epidemic. 
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1. Introduction 
The World Health Organization (WHO) recognizes obe-
sity as a disease of global epidemic proportions [1]. Con- 
trary to western perceptions, now even the Chinese have 
an obesity problem [2]. Caloric imbalance (over-eating 
and a lack of exercise) that has been for many decades, 
widely acknowledged as the cause of obesity, is now 
regarded as an inadequate explanation; sleep debt, endo- 
crine disruptors, pharmaceutical iatrogenesis [3] as well 
as parental influences, economic and genetic predisposi- 
tions are suggested [4,5]. Body frame size differences 
were recently postulated as contributive to individual 
variation in obesity [6]. This opens up the perception that 
some other specific causes may be contributing to the 
epidemic of obesity. 
Soy is ubiquitously used for mass-produced foods, both 
for humans and for farm animals, especially industrial- 
ized farm animals and feed lots. According to Soyatech, 
“world soybean production has increased by over 500% 
in the last 40 years,” [www.soyatech.com/soyfacts.htm]. 
Soy is a vegetable that has become a “politically correct 
food,” and is promoted as a source of abundant health for 
the 21st century by the soyfood processing industry. Part  
of this claim is that the cheap protein from soy is equiva-
lent or better for humans than that from animal sources. 
The soy industry generates an extensive array of new 
products affecting most of the global processed food 
supply with new processed foods promoted daily. Soy 
use takes many forms, either directly, in the form of soy 
flour and soy oil throughout the baking, bread-making, 
cooking and supermarket supply industries, or extensive 
in the restaurant, hotel, cafeteria and multiple fast food 
industry. Soy-rich processed food items include soy milk, 
soy-cheese, soy-yogurts, textured vegetable protein and a 
range of imitation meat products (often combined with 
other possible excess weight promoting co-factors). Di- 
rectly or indirectly soy products, either with soybean 
extracts, soybean oil or both are heavily used in the large 
scale snack food industry. Soy lecithin is also used 
widely in the worldwide confectionery industry and the 
pharmaceutical industry, not only in the production of 
capsules, but also in their medical contents. Soy oil is 
hydrogenated to create many medical formulations (e.g. 
compounded in commonly used beta blockers). Soy is 
also consumed by humans indirectly via feed through 
industrialized farm animals, particularly those bred for  
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human consumption. (For example, soy compounded 
pellets for caged animals which encourage the fattening 
process for market, including chickens and fish farms.) A 
commonly used argument for the benefits of soy, has 
been its supposedly extensive use in Asian cultures for 
thousands of years. However, most traditional Asian soy 
use has relied on methods such as fermentation to pro- 
duce flavouring agents, soups and garnishes, rather than 
being used as the main dietary staple except in the his- 
torical past, in times of destitution. Historically, Asian 
cultures in the main, have always preferred real meat 
products (especially pork and seafood) to artificial imita- 
tion meat products. With regards to soy, western methods 
of soy processing and consumption predominately use 
unfermented soybeans. Such processes are and were, 
quite different from traditional Asian fermented soy pro- 
ducts, thus altering contents and quantities of soy prod- 
ucts consumed. The fact that Western methods of proc- 
essing and consumption have now been exported back to, 
and readily adopted by Asian cultures, have made the 
modern western technologically based soy products avail- 
able to be consumed worldwide. 
Here, we advance a hypothesis that there is a correla- 
tion between soy consumption and the rise in obesity 
because of an unprecedented rise in consumption and 
ingestion of xenoestrogens and antinutrients contained in 
unfermented soy products. 
Foods from soy can alter normal metabolic processes 
in a way that may lead to excess weight gain. Soy con- 
tains a number of phytates, trypsin inhibitors as well as 
phytoestrogens and topoisomerase II toxins, in larger 
quantities than most other vegetables. The xenoestrogens 
in soy behave like human estrogens and encourage fat 
accumulation in most mammals including humans. Thus, 
an argument could be made that the consumption of soy 
food products may contribute to obesity. The causes of 
the observed relationship may possibly belong to two 
categories: soy phytoestrogens and soy’s ability to inhibit 
absorption of essential nutrients. Phytoestrogens, in par- 
ticular Genistein and similar substances contained in soy, 
interfere with metabolism in many ways [7,8], and may 
induce increased fat accumulation and distribution over 
the body depending on its intake levels [9]. The anti- 
nutrients in soy such as trypsin inhibitors and phytates 
[10,11] block the absorption of minerals such as iodine, 
zinc, iron, magnesium, copper and chromium, and many 
others, [12-14] and may thus require increased food con- 
sumption to compensate for the restricted intake of these 
minerals manifested by continual snacking and consum- 
ing larger quantities of food. Such foods often involve 
refined carbohydrates and flavour enhancers which also 
contribute to obesity in making soy palatable. 
The effects of soy on the thyroid have been well docu- 
mented [14,15]. Thyroid activity compromised by con- 
sumption of iodine inhibitors, as found in soy [16-19] 
leads to reduced metabolic activity which may translate 
into lethargy with reduced inclination to be in- volved in 
physical activities thereby encouraging further weight 
gain. Furthermore, low thyroxine levels have a negative 
domino effect on the liver, which generates more fatty 
acids and cholesterol encouraging further weight gains 
[17-19]. 
Soy may also exert an inhibitive influence on the trace 
element chromium [20] reducing the amount of available 
chromium, which in turn, also reduces the effectiveness 
of insulin [21-23]. Chromium is essential to improving 
glucose tolerance in mammals [23-25]. Western diets are 
typically low in chromium and if the microscopic levels 
are reduced even further by consumption of processed 
foods containing the anti-nutrients abundant in soy that 
block chromium, it is possible, that it will in turn also 
contribute to increased fatness and thus obesity [23-25] 
quite aside from problems of insulin resistance and re- 
lated consequences for any associated diabetes morbid- 
ities. The chain of events that soy seems to influence gets 
longer with each type of newly developed processed food. 
An argument could also be made that many foods con- 
sumed today that have the appearance similar to what we 
consumed 30 - 50 years ago, are substantially different in 
both nutrient and solid content that have been partly or 
totally replaced by soy in its many forms. Hence, the im- 
portance of the necessity of correct labeling and properly 
detailed nutrition panels. 
2. Materials and Methods 
WHO data on the prevalence of obesity, FAO data on 
soy consumption per country and UN information on 
GDP and on caloric consumption per country were used 
to explore relationships between soy consumption and 
obesity. Information published by the WHO by country 
on the percentage of persons with body mass index (BMI) 
greater than 30 kg/m2 was used (http://who.int/research/ 
en). The gross domestic product (GDP in US$) per capita 
and the caloric consumption per capita were obtained 
from United Nations sources (http://unstats.un.org/unsd/ 
snaama/). Data from the Food and Agriculture Organiza- 
tion (FAO) generated information on soy consumption 
by country (http://faostat.fao.org/) which was converted 
to per capita by dividing it over population of each coun- 
try. Each country was treated as an individual in the 
analysis. Data were analysed statistically using Microsoft 
Excel. Linear and curvilinear bivariate regressions, and 
comparisons between means (t-test, unpaired, two tailed) 
were used. All countries for which information was 
available were analysed. Some countries were included 
in special groupings sharing specific characteristics like 
language or geo-political status. For particular analyses, 
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the number of countries included may have differed 
somewhat because all information was not uniformly 
available for all countries, as they may not have supplied 
data to relevant agencies (e.g. there were no data on soy 
consumption in Canada available form the FAO source). 
The groupings were Westernised English Speaking which 
included Australia, Bahamas, Barbados, Canada, Jamaica, 
Malta, New Zealand, South Africa, United States of 
America, European Union, including also countries of 
the European Economic Area and Switzerland, Austria, 
Belgium, Bulgaria, Czech Republic, Denmark, Estonia, 
Finland, France, Germany, Greece, Hungary, Italy, Ice- 
land, Ireland, Latvia, Lithuania, Luxembourg, Malta, 
Netherlands, Norway, Poland, Portugal, Romania, Slo- 
vakia, Slovenia, Spain, Sweden, Switzerland, United 
Kingdom, and Latin America: Argentina, Bahamas, Bar- 
bados, Belize, Bolivia, Brazil, Chile, Costa Rica, Colom- 
bia, Cuba, Dominican Republic, Ecuador, El Salvador, 
Guatemala, Guyana, Haiti, Honduras, Jamaica, Mexico, 
Nicaragua, Panama, Paraguay, Peru, Trinidad and To- 
bago, Uruguay, Venezuela. Countries not included in 
those special groupings were also analysed when the 
entire world was considered. 
3. Results 
The analysis shows that although the prevalence of obe- 
sity (% of people with BMI > 30 kg/m2), in general, in- 
creases with increased caloric intake and GDP, the rela- 
tionship is different for different groups of countries 
(Figure 1). Especially, the prevalence of obesity is higher 
in the group of Westernised English-speaking countries 
(e.g. USA, Canada, Australia, NZ) and countries located 
in both Americas. The same is true for the relationship 
between the prevalence of obesity and GDP (Figure 2). 
Most notably, higher levels of obesity are observed at 
different levels of GDP and caloric intake in westernised 
English-speaking countries and in Latin America that 
have similar high soy consumption levels. In contrast, 
European Union countries, despite having, on average, 
higher GDP and caloric intake than westernised Eng- 
lish-speaking countries, have only half the levels of obe- 
sity. This is directly attributable to consuming only half 
the amount of soy (Table 1, last column). The differ- 
ences between prevalence of obesity and soy consump- 
tion in EU and other two groups of countries are signifi- 
cant (unpaired t-test, p < 0.05). BMI EU vs Westernised 
English speaking countries t = 2.77, BMI EU vs Latin 
America t = 2.43. Soy EU vs Westernised English 
speaking countries t = 1.96, Soy EU vs Latin America t = 
3.98. Worldwide, the prevalence of obesity is exponen-
tially correlated with soy consumption standardised on 
caloric intake (Figure 3). 
4. Discussion 
We have observed significant relationships between soy 
consumption and the prevalence of obesity. Despite the 
 
 
Figure 1. Relationship between prevalence of obesity and caloric intake, in groups of countries. 
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Figure 2. Relationship between prevalence of obesity and GDP in, groups of countries. 
 
Table 1. Comparison of prevalence of obesity and soy consumption in variously grouped countries. 
Contributing factors  
Country grouping 
N %BMI > 30 GDP/capita Caloric intake Soy per capita
World total 142 15.6 14,372 2688 17.17 
Westernisd English speaking 9 30.4 22,755 3127 31.56 
European union* 29 14.1 31,120 3347 16.07 
Latin America 20 18.4 8135 2640 28.92 
*Includes EEA countries and Switzerland. 
 
use of fairly crude measures of soy consumption and 
obesity derived from collective statistics, we have a range 
of interesting and statistically relevant results. Statistics 
reported by various countries may have various inaccu- 
racies, in the case of larger countries averaging over the 
entire economy and the entire population may be ques- 
tionable. BMI itself is an approximate measure of fatness 
and its reporting by country depends on local surveys of 
only a fraction of each population. (e.g. Australian Bu-
reau of Statistics surveys some 10,000 adults out of just 
over 20 million inhabitants) [26]. This explains scatter of 
the individual datum points. 
The recognition of the worldwide problem of obesity 
by the WHO has put the issue fairly and squarely on all 
governments agenda as an item that needs special fund-
ing consideration and deliberation from many quarters, 
besides biophysical wellbeing. Perhaps people in envi-
ronments which experience frequent famine may see it as 
a positive [27], whereas in most countries or places, 
many obese people are not happy with their lot and in 
consequence develop a range of psychological problems 
and defenses, that also compromise their health placing a 
further burden on themselves and the people who care for 
them, as well as most publicly subsidized medical sys-
tems [28]. 
Much nutritional advice is still based on fallacious 
concepts promulgated from the 1950’s, 60’s and 70’s 
without taking full advantage of the data, from long term 
studies that included and spanned those decades. The 
Frammingham Heart Study was one of the major studies 
that has now arrived at entirely different conclusions, 
advanced, by the misleading saturated fat and cholesterol   
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Figure 3. Relationship between prevalence of obesity and soy consumption standardized on caloric intake by country. 
 
interpretations, aggressively promoted by Ancel Keyes 
which he derived from the hand-picked “Seven Nation 
Study” in the 1950’s. For example, the Frammingham 
Heart study that extended from the late 1940’s to the 
present day has enabled us to see that one of the real cul- 
prits behind heart disease and being over-weight, was not 
so much the natural saturated fatty acids and cholesterol, 
but the artificial transfats (artificially saturated fats) much 
preferred by the cooking and baking industry using poly- 
unsaturated oils and margarines. Margarines were pre- 
ferred because transfats gave long shelf life properties to 
their products [29,30]. The transfats and margarines were 
produced from predominantly polyunsaturated vegetable 
oils, that were hydrogenated, of which the main one that 
was cheap to use, was soybean oil. In the last decade or 
so, with the gradual realization of the health benefits of 
the natural monounsaturated, and saturated fats new mar- 
garines have been developed. Some nutritionists and/or 
manufacturers, have pushed the strange idea, for example 
that by combining margarine with a small percentage of 
olive oil, makes the margarine a better product. It cer-
tainly is a more marketable product, but lest it escape us, 
all it means, is that any efficacy inherent in the olive oil 
is compromised by the artificiality of the hydrogenated 
polyunsaturated vegetable oil, which usually means soy- 
bean oil. With marketing duplicity, any label that hides 
behind a vegetable oil termed description where the 
manufacturer does not spell out the types of vegetable 
oils that are used, in any product under consid- eration, 
skepticism should prevail and possibly conclude that the 
oil used will most likely be the cheaper soybean oil. This 
could mean that soy consumption may be even higher 
than the figures show. 
Although soy consumption shows statistical coinci- 
dence with the prevalence of obesity, the awareness of 
numerous other factors that are involved in increasing 
fatness and obesity [3,10] such as caloric imbalance, ge- 
netic predisposition and metabolic syndrome still need to 
be taken into account. The fact that soy products often 
require other factors for palatability that are also impli- 
cated in the obesity equation [31] should not escape us. 
Nonetheless the statistically significant relationship that 
has been observed, between soy and obesity, strongly 
indicates and thereby requires that it should be scruti- 
nised with much more specific attention than has so far 
been cursorily given. 
Perhaps the way to combat obesity that seems to have 
escaped many analysts’ attention, would be to not only 
consider programs of multiple interventions, but to also 
take more seriously a far more careful analysis and re-
search, of the composition of foods, that were not part of 
our evolutionary history, especially those modern foods 
containing soy that are promoted and consumed in the 
greatest amounts, which are now so widespread through-
out the food supply. 
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